We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+12.29%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.07B
AUM Growth
+$194M
Cap. Flow
-$187M
Cap. Flow %
-4.59%
Top 10 Hldgs %
32.7%
Holding
1,071
New
40
Increased
551
Reduced
421
Closed
53

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$7.41M
2
APH icon
Amphenol
APH
+$6.83M
3
ARE icon
Alexandria Real Estate Equities
ARE
+$6.52M
4
ETN icon
Eaton
ETN
+$5.59M
5
IP icon
International Paper
IP
+$5.26M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.4M
2
CMI icon
Cummins
CMI
+$12.3M
3
MSFT icon
Microsoft
MSFT
+$12.1M
4
APD icon
Air Products & Chemicals
APD
+$11.6M
5
AMZN icon
Amazon
AMZN
+$9.21M

Sector Composition

Rank Sector Weight
1 Technology 30.67%
2 Healthcare 13.54%
3 Consumer Discretionary 13.48%
4 Financials 10.46%
5 Communication Services 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
301
Wayfair
W
$14.2B
$1.82M 0.04%
6,263
+63
+1% +$17.2K
ZBRA icon
302
Zebra Technologies
ZBRA
$16.9B
$1.81M 0.04%
7,156
-33
-0.5% -$8.88K
CTSH icon
303
Cognizant
CTSH
$29.1B
$1.81M 0.04%
26,016
-28
-0.1% -$1.82K
PTC icon
304
PTC
PTC
$17.2B
$1.8M 0.04%
21,799
+1,524
+8% +$130K
EPAM icon
305
EPAM Systems
EPAM
$5.92B
$1.79M 0.04%
5,538
+42
+0.8% +$12.5K
TTC icon
306
Toro Company
TTC
$9.41B
$1.79M 0.04%
21,327
+1,637
+8% +$123K
ABMD
307
DELISTED
Abiomed Inc
ABMD
$1.78M 0.04%
6,443
+44
+0.7% +$12.7K
DAY
308
DELISTED
Dayforce
DAY
$1.77M 0.04%
21,432
+4,611
+27% +$361K
BF.B icon
309
Brown-Forman Class B
BF.B
$12.5B
$1.76M 0.04%
23,316
+12
+0.1% +$859
ALNY icon
310
Alnylam Pharmaceuticals
ALNY
$31.7B
$1.74M 0.04%
11,965
+137
+1% +$19.5K
TREX icon
311
Trex
TREX
$4.63B
$1.73M 0.04%
24,197
+1,839
+8% +$127K
QDEL icon
312
QuidelOrtho
QDEL
$1.03B
$1.72M 0.04%
7,852
+545
+7% +$122K
GEN icon
313
Gen Digital
GEN
$18.4B
$1.7M 0.04%
81,557
+1,964
+2% +$42.5K
TFX icon
314
Teleflex
TFX
$5.94B
$1.68M 0.04%
4,936
+22
+0.4% +$8.15K
ULTA icon
315
Ulta Beauty
ULTA
$22.1B
$1.68M 0.04%
7,479
+45
+0.6% +$9.68K
SAM icon
316
Boston Beer
SAM
$1.88B
$1.65M 0.04%
1,870
+98
+6% +$77.4K
AEP icon
317
American Electric Power
AEP
$66.5B
$1.65M 0.04%
20,168
-87
-0.4% -$7.17K
DD icon
318
DuPont de Nemours
DD
$18.5B
$1.65M 0.04%
23,657
-65
-0.3% -$4.55K
DDOG icon
319
Datadog
DDOG
$85.1B
$1.63M 0.04%
15,973
+74
+0.5% +$6.44K
OLED icon
320
Universal Display
OLED
$3.84B
$1.62M 0.04%
8,967
+708
+9% +$121K
PODD icon
321
Insulet
PODD
$10.1B
$1.62M 0.04%
6,842
+303
+5% +$63.8K
RGEN icon
322
Repligen
RGEN
$10B
$1.62M 0.04%
10,961
+1,267
+13% +$181K
TDG icon
323
TransDigm Group
TDG
$65.5B
$1.62M 0.04%
3,402
+122
+4% +$57.4K
GGG icon
324
Graco
GGG
$12.8B
$1.61M 0.04%
26,269
+2,657
+11% +$148K
DLR icon
325
Digital Realty Trust
DLR
$69B
$1.6M 0.04%
10,901
-21
-0.2% -$3.15K

Similar funds

Xponance's Q3 2020 Portfolio in Review

As of Q3 2020, Xponance held 1,071 positions worth $4.07B, up 5% from $3.87B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Xponance withdrew a net $187M in Q3 2020, closing 53 positions and reducing 421 holdings. Its most notable exit was Alaska Air, an estimated $2.69M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Xponance opened a new position in iShares MSCI India Small-Cap ETF worth $1.98M.

  • Xponance's largest Q3 2020 buy was iShares MSCI India Small-Cap ETF: 55,376 shares worth $1.98M.
  • Xponance added most to Aflac in Q3 2020, an estimated $7.41M increase.
  • Xponance's biggest Q3 2020 reduction was Apple, cutting an estimated $17.4M.
  • Xponance fully exited Alaska Air in Q3 2020, selling an estimated $2.69M.
  • Xponance's ten largest holdings make up 33% of its $4.07B portfolio in Q3 2020.
  • Xponance opened 40 new positions and closed 53 in Q3 2020.
  • Xponance's portfolio value rose 5% quarter-over-quarter to $4.07B.

Based on Xponance's 13F filing for Q3 2020, filed 26 Oct 2020.